Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 25.89%
March 31, 2026 24.35%
December 31, 2025 21.42%
September 30, 2025 23.17%
June 30, 2025 24.10%
March 31, 2025 23.24%
December 31, 2024 24.34%
September 30, 2024 25.01%
June 30, 2024 25.21%
March 31, 2024 26.17%
December 31, 2023 26.84%
September 30, 2023 29.33%
June 30, 2023 29.60%
March 31, 2023 29.41%
December 31, 2022 30.07%
September 30, 2022 30.90%
June 30, 2022 30.00%
March 31, 2022 29.98%
December 31, 2021 29.88%
September 30, 2021 31.87%
June 30, 2021 29.83%
March 31, 2021 29.98%
December 31, 2020 29.13%
September 30, 2020 28.59%
June 30, 2020 28.84%
Date Value
March 31, 2020 30.21%
December 31, 2019 30.69%
September 30, 2019 30.47%
June 30, 2019 31.17%
March 31, 2019 31.00%
December 31, 2018 30.46%
September 30, 2018 31.10%
June 30, 2018 30.52%
March 31, 2018 30.61%
December 31, 2017 30.17%
September 30, 2017 30.62%
June 30, 2017 31.25%
March 31, 2017 31.12%
December 31, 2016 30.93%
September 30, 2016 31.03%
June 30, 2016 31.12%
March 31, 2016 31.01%
December 31, 2015 31.42%
September 30, 2015 31.53%
June 30, 2015 29.96%
March 31, 2015 29.42%
December 31, 2014 28.83%
September 30, 2014 28.81%
June 30, 2014 29.15%
March 31, 2014 29.12%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
InfuSystem Holdings, Inc. 56.69%
Circle8 Group, Inc. 0.00%
Centene Corp. 0.00%
Cardinal Health, Inc. 3.87%
McKesson Corp. 3.31%